Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PsA-TT-007 infant meningococcal A vaccine study
PACTR201110000328305Completed
- Sponsor
- Serum Institute of India
- Start
- Jan 2012
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Trial of MenAfriVac in meningococcal disease (5 arms), sponsored by Serum Institute of India. Primary endpoint: Seroconversion for meningococcal A antibodies. Started Jan 2012; status: completed.
02
Drugs
MenAfriVac
03
Conditions
meningococcal disease
Beyond the preview
Go deeper on PACTR201110000328305.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201110000328305.